Compare Cassava Sciences Inc (FLNA) vs Williams Companies Inc (WMB) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
Cassava Sciences Inc vs Williams Companies Inc — how do they compare? Cassava Sciences Inc trades at $1.07 (market cap $53.14M), while Williams Companies Inc trades at $74.62 (market cap $90.97B). The key difference: Williams Companies Inc is far larger — about 1711.9× Cassava Sciences Inc's market cap, and Williams Companies Inc pays a 2.82% dividend while Cassava Sciences Inc pays none. Which is the better fit depends on your goals.
| FLNA | WMB | |
|---|---|---|
Market Cap | $53.14M | $90.97B |
Sector | Health | Energy |
52-Week High | $4.64 | $79.40 |
52-Week Low | $1.09 | $56.51 |
Enterprise Value | -$33.43M | $120.35B |
Dividend Yield | — | 2.82% |
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
FLNA trades at $1.06, down 2.75% today, with a bearish technical signal from moving averages but neutral oscillators. The stock shows a low P/B of 0.78, yet profitability metrics are negative, including a -79.59% ROE and -$90.97M net income for 2025. Recent Q1 2026 earnings beat expectations, and analyst consensus is 66.7% buy. News highlights Q1 financial results and a scientific presentation on TSC-related epilepsy therapies.
Outlook remains speculative due to persistent losses and negative cash flows, offset by strong analyst support and recent earnings beats. Key risks include funding needs for drug development and competitive pressures, while potential upside hinges on clinical progress in TSC-related epilepsy treatments.
Williams Companies (WMB) trades at $74.76, down 1.61% on the day, with a neutral technical outlook and strong analyst support. The stock shows robust profitability with a 23.4% net margin and 21.95% ROE, while recent news highlights a $5.34 billion Blackstone-led investment for power projects. Cash flow trends improved in 2025, with net cash flow turning positive to $3 million after a 2024 deficit.
WMB presents a favorable long-term outlook with a consensus price target of $85.67 and no sell ratings among analysts. Risks include high debt levels and exposure to natural gas price volatility, but the company's fee-based midstream model and strategic investments in energy infrastructure support dividend growth and earnings potential.
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Top news
Latest headlines on both assets
Top news
Latest headlines on both assets
About Cassava Sciences Inc
Cassava Sciences Inc is a clinical-stage biotechnology company engaged in developing a scientific approach for the treatment and detection of Alzheimer's disease. Its therapeutic product candidate is called simufilam, and it is a novel treatment for Alzheimer's disease
Read more on FLNA →About Williams Companies Inc
Williams is a midstream energy company that owns and operates the large Transco and Northwest pipeline systems and associated natural gas gathering, processing, and storage assets. In August 2018, the firm acquired the remaining 26% ownership of its limited partner, Williams Partners.
Read more on WMB →
